Search

Current filters: Treatment, Drug treatment strategies, Research summary

Improved health when treatment for both hepatitis C and opioid use disorder are offered

2020, CATIE
Research summary - Webpage

More dual HIV regimens are coming

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Switching to Dovato (dolutegravir + 3TC) from a TAF-based regimen

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Dovato (dolutegravir + 3TC) in initial HIV treatment

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

B.C. study finds that providing ART and methadone in the same facility helps adherence

2019, CATIE
Research summary - Webpage

Can high-dose dolutegravir be a rescue therapy?

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

De-simplifying single-tablet regimens for HIV treatment

2019, CATIE
Research summary - Webpage

Dual drug therapy—impact on the HIV reservoir

From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage

Italian study explores dual drug regimens as maintenance treatment

From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage

Dual maintenance therapy with dolutegravir + rilpivirine

From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage